Author:
Haferlach T,Nagata Y,Grossmann V,Okuno Y,Bacher U,Nagae G,Schnittger S,Sanada M,Kon A,Alpermann T,Yoshida K,Roller A,Nadarajah N,Shiraishi Y,Shiozawa Y,Chiba K,Tanaka H,Koeffler H P,Klein H-U,Dugas M,Aburatani H,Kohlmann A,Miyano S,Haferlach C,Kern W,Ogawa S
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference33 articles.
1. Brunning R, Orazi A, Germing U, Le Beau MM, Porwit A, Baumann I et al. Myelodysplastic syndromes. In: Swerdlow S, Campo E, Lee Harris N, Jaffe ES, Pileri SA, Stein H, et al(eds). 4 edn, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008; pp 87–93.
2. Cazzola M, la Porta MG, Travaglino E, Malcovati L . Classification and prognostic evaluation of myelodysplastic syndromes. Semin Oncol 2011; 38: 627–634.
3. Greenberg P, Cox C, Le Beau MM, Fenaux P, Morel P, Sanz G et al. International Scoring System for evaluating prognosis in myelodysplastic syndromes. Blood 1997; 89: 2079–2088.
4. Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 2007; 25: 3503–3510.
5. Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F et al. Revised International Prognostic Scoring System (IPSS-R) for myelodysplastic syndromes. Blood 2012; 120: 2454–2465.